Egl-9 Family Hypoxia Inducible Factor 2 (EGLN2) (C-Term) Peptide
-
- Target See all PHD1 (EGLN2) products
- PHD1 (EGLN2) (Egl-9 Family Hypoxia Inducible Factor 2 (EGLN2))
- Protein Region
- C-Term
- Origin
- Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- FWSDRRNPHE VKPAYATRYA ITVWYFDAKE RAAARDKYQL ASGQKGVQVP
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-Egln2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PHD1 (EGLN2) (Egl-9 Family Hypoxia Inducible Factor 2 (EGLN2))
- Background
-
HIF-prolyl hydroxylase 1, might be involved in might play a role in hypoxic preconditioning.
Alias Symbols: MGC93662, MGC93666, PHD-1, PHD1, HPH-1, HPH-3, HIF-PH1
Protein Size: 415 - Molecular Weight
- 45 kDa
- Gene ID
- 308457
- NCBI Accession
- NM_001004083, NP_001004083
- UniProt
- Q6AYU4
-